Home Health Care News October 30, 2024
Joyce Famakinwa

Medicare Advantage (MA) star ratings have become a hot topic for Humana Inc. (NYSE: HUM).

On Oct. 18, the company filed a lawsuit against the U.S. Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) over its drop in star ratings.

The number of Humana MA plans rated 4-star or higher is expected to see a major decrease next year. The decline could impact the company’s bonus payments from CMS, as well as revenue generally.

The lawsuit alleges that federal regulators actions were “arbitrary and capricious” when it came to calculating Humana’s quality scores. Humana wants the court to vacate the company’s 2025 star ratings, and calls for a recalculation.

The company is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare Advantage, Payer, Payment Models, Value Based
20 payer executives' top priorities for 2025
6 GI payer updates in 2024, where they stand now
Health-care stocks fall as lawmakers, patients push for changes to their business models
These Entrepreneurs Are Using AI To Fight Health Insurance Claims Denials
Enhabit CEO On Company’s New Home Health Agreement With UnitedHealthcare

Share This Article